ARTICLE | Company News
DUSA, Sun Pharmaceutical deal
November 12, 2012 8:00 AM UTC
Sun will acquire DUSA for $8 per share in cash, or about $230 million. The price is a 38% premium to DUSA's close of $5.78 on Nov. 7, before the deal was announced. The boards of both companies have a...